Insider · CIK 0001534357

Vos Ellen O'Connor

CIK 0001534357 Name as filed on the most recent filing

Filed as Vos Ellen O'Connor (9)

33 transaction lines · from 9 filings · filed 2017-05-31 to 2023-07-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

33 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-07-24 P, Open-market purchase Aspira Women's Health Inc.AWH 15,001, acquired Open Form 4 filing 0000926617-23-000061
2022-08-16 P, Open-market purchase OptimizeRx CorpOPRX 7,955, acquired Open Form 4 filing 0001213900-22-049031
2021-10-28 P, Open-market purchase Modular Medical, Inc.MODD 149,999, acquired Open Form 4 filing 0001019056-21-000555
2020-03-31 P, Open-market purchase OptimizeRx CorpOPRX 8,750, acquired Open Form 4 filing 0001213900-20-008316
2019-11-13 P, Open-market purchase OptimizeRx CorpOPRX 5,772, acquired Open Form 4 filing 0001213900-19-023370
2018-10-08 P, Open-market purchase OptimizeRx CorpOPRX Not reported Open Form 4 filing 0001213900-18-013770
2018-06-29 P, Open-market purchase OptimizeRx CorpOPRX Not reported Open Form 4 filing 0001213900-18-008681
2018-06-25 P, Open-market purchase OptimizeRx CorpOPRX 2 lines 14,197, acquired Open Form 4 filing 0001213900-18-008317
2018-06-22 P, Open-market purchase OptimizeRx CorpOPRX 2 lines 4,655, acquired Open Form 4 filing 0001213900-18-008317
2017-05-03 P, Open-market purchase OptimizeRx CorpOPRX 750, acquired Open Form 4 filing 0001213900-17-006023
2017-04-12 P, Open-market purchase OptimizeRx CorpOPRX 1,480, acquired Open Form 4 filing 0001213900-17-006023
2017-03-24 P, Open-market purchase OptimizeRx CorpOPRX 810, acquired Open Form 4 filing 0001213900-17-006023
2017-03-23 P, Open-market purchase OptimizeRx CorpOPRX 810, acquired Open Form 4 filing 0001213900-17-006023
2017-03-22 P, Open-market purchase OptimizeRx CorpOPRX 1,620, acquired Open Form 4 filing 0001213900-17-006023
2017-03-21 P, Open-market purchase OptimizeRx CorpOPRX 800, acquired Open Form 4 filing 0001213900-17-006023
2017-03-20 P, Open-market purchase OptimizeRx CorpOPRX 810, acquired Open Form 4 filing 0001213900-17-006023
2017-03-17 P, Open-market purchase OptimizeRx CorpOPRX 810, acquired Open Form 4 filing 0001213900-17-006023
2017-03-16 P, Open-market purchase OptimizeRx CorpOPRX 1,640, acquired Open Form 4 filing 0001213900-17-006023
2017-03-14 P, Open-market purchase OptimizeRx CorpOPRX 850, acquired Open Form 4 filing 0001213900-17-006023
2017-03-13 P, Open-market purchase OptimizeRx CorpOPRX 1,620, acquired Open Form 4 filing 0001213900-17-006023
2017-03-10 P, Open-market purchase OptimizeRx CorpOPRX 810, acquired Open Form 4 filing 0001213900-17-006023
2017-03-06 P, Open-market purchase OptimizeRx CorpOPRX 850, acquired Open Form 4 filing 0001213900-17-006023
2017-03-01 P, Open-market purchase OptimizeRx CorpOPRX 700, acquired Open Form 4 filing 0001213900-17-006023
2017-02-28 P, Open-market purchase OptimizeRx CorpOPRX 710, acquired Open Form 4 filing 0001213900-17-006023
2017-02-21 P, Open-market purchase OptimizeRx CorpOPRX 750, acquired Open Form 4 filing 0001213900-17-006023
2017-02-15 P, Open-market purchase OptimizeRx CorpOPRX 770, acquired Open Form 4 filing 0001213900-17-006023
2017-02-10 P, Open-market purchase OptimizeRx CorpOPRX 1,400, acquired Open Form 4 filing 0001213900-17-006023
2017-02-09 P, Open-market purchase OptimizeRx CorpOPRX 1,500, acquired Open Form 4 filing 0001213900-17-006023
2017-02-08 P, Open-market purchase OptimizeRx CorpOPRX 2 lines 1,490, acquired Open Form 4 filing 0001213900-17-006023
2017-02-06 P, Open-market purchase OptimizeRx CorpOPRX 770, acquired Open Form 4 filing 0001213900-17-006023

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 33
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Vos Ellen O'Connor, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001534357

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.